1 / 9

IV Fluids Manufacturing Unit

Over the past few years, hectic work schedules, unhealthy lifestyles, dropped physical activities, and malnutrition has developed the rate of chronic diseases around the globe. And these factors have boosted the demand for body supplements and intravenous solutions. IV fluid helps in treating electrolyte imbalances, medications, transfusion of blood, rehydration and it also helps in chemotherapy. The demand for Intravenous fluid is rising, because it is more effective than oral ingestion. Growing adoption of intravenous fluids has spurred the growth of the market, and it is expected that the market will advance with high growth rate.

MeticulousBPlans
Télécharger la présentation

IV Fluids Manufacturing Unit

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. IV Fluid Manufacturing Business Available Reports on this Title – http://meticulousbplans.com/product/iv-fluids-manufacturing-unit/ • Business Feasibility Study Report • Business Model • Project Report • Business Plan • Detailed Project Report

  2. Executive Summary and Analysis • Intravenous fluids present a combination of nutrients that support patients to get essential nutrition. It helps in treating electrolyte imbalances, medications, transfusion of blood, rehydration and it also helps in chemotherapy. • The demand for Intravenous fluid is rising, because it is more effective than oral ingestion. The primary costumers for these manufacturing units are Hospitals, Clinics, Dialysis centers, Home care settings. • As per MBP analysis, the global Intravenous Fluid market size was valued at US$ 8,372.0 million in 2019, and is expected to witness a CAGR of 6.1% over the forecast period (2019 – 2027).

  3. Competitive Advantage & Pre-requisite Pre-requisite Revenue Generation Skilled Employee Government Support High Growth Feasibility Business License 3 4 2 Competitive Advantages Fund Plan 5 1 Eternal Market Market Potential Required Technical Expert

  4. Market Dynamics Opportunities Growth drivers • More effective than oral ingestion. • Increasing government endorsement. • Increasing prevalence of chronic diseases. • Growing acceptance of vitamin C intravenous for colorectal cancer. Threats Challenges • Stringent government regulations. • Ensuring patient safety. • Ignorance of manufacturing guidelines may affect the patient safety.

  5. Financial Summary • Project – IV Fluids Manufacturing Unit • Product Type– Crystalloids, Colloids, Blood products , etc. • Initial Investment – 70 - 80 Lakh INR • Capital Investment – 35 - 45 Lakh INR

  6. Project Profile – Project Details Manpower Required Legal Requirements Product Portfolio IV Fluid Manufacturing Business Skilled & Executive Employee Business & Industry Requirement Employment Generation List Product Portfolio Skilled and Unskilled Labor – XX Driver – X Plant executive – X ( for Dock, Process, Product, Store & for Lab) Supervisor – X Operator -X Admin Executive – X (Admin, HR, Account & Finance) Marketing Executive – x (Sales & Marketing) Director – X (Admin, Operation, Marketing & Finance) PAN & TAN MSME Registration Shop Act GST XXX XXX XXX XXX XXX XXX • Dextrose • Albumin • Mannitol • RBC • WBC, etc.

  7. Start-up Budget and Production Details Slide Title • Budget (INR) • Pre-operative Expenses – XX,00,000 • Fixed Capital – XX,00,00,000 • Working Capital ( X Month) – X,00,00,000 • Total Investment – XX,00,00,000 • Cost Per Unit – XX INR • Price Per Unit – XX INR • Profitability – XX % • BEP – XX Years • ROI – XX % Production Details Operation – 1st Year – XX%, Second Year – XX% and 3rd Year – XXX% Working Days – X00 Per Annum Land Type – NA Power Requirement – XX – X00 Kw (x Phase) Water Requirement – XX,000 LPD Transportation – XX, Km

  8. Recent News(timeline) & MBS Analysis • Eurolife Healthcare, India's largest maker of intravenous (IV) fluid formulations, plans to expand into highly-regulated markets such as Europe and the US, on back of its acquisition of Teva's Intravenous Infusions plant in Hungary last month. • A Kerala-based health-tech startup - Evelabs came up with a smart IV therapy system “Dripo” that regulate and monitor IV drips. • 12-year-old girl “Ella Casano” creates teddy bear cover for children’s hospital IV drips.

  9. Thank You Meticulous Business Plans For detailed reports and plans, Contact us on Following Details.

More Related